- Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
-
Radhakrishnan Y, Duriseti P, Chebib FT
- KMID: 2535388
- Kidney Res Clin Pract.
- 2022 Jul;41(4):422-431.
- doi: 10.23876/j.krcp.21.309
Autosomal dominant polycystic kidney disease (ADPKD) is the reported etiology in 10% of end-stage kidney disease (ESKD) patients and has an estimated prevalence of 12.5 million cases worldwide across all... -
- CITED
-
- Close
- SHARE
-
- Close
